Publikationen im NUM

Hier finden Sie eine Liste der Publikationen, die im Zusammenhang mit dem Netzwerk Universitätsmedizin in der ersten und zweiten Förderphase entstanden sind.

Wyler E, Adler JM, Eschke K, Teixeira Alves G, Peidli S, Pott F, Kazmierski J, Michalick L, Kershaw O, Bushe J, Andreotti S, Pennitz P, Abdelgawad A, Postmus D, Goffinet C, Kreye J, Reincke SM, Prüss H, Blüthgen N, Gruber AD, Kuebler WM, Witzenrath M, Landthaler M, Nouailles G, Trimpert J. Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics. Mol. Ther.. 2022 Mai; 30(5):1952—1965.      [DOI]  [Pubmed] 
Fervers P, Kottlors J, Persigehl T, Lennartz S, Maus V, Fischer S, Styczen H, Deuschl C, Schlamann M, Mpotsaris A, Zubel S, Schroeter M, Maintz D, Fink G, Abdullayev N. Meaningful use of imaging resources to rule out cerebral venous sinus thrombosis after ChAdOx1 COVID-19 vaccination: Evaluation of the AHA diagnostic algorithm with a clinical cohort and a systematic data review. J Clin Neurosci. 2022;      [DOI] 
Krishnaratne S, Littlecott H, Sell K, Burns J, Rabe JE, Stratil JM, Litwin T, Kreutz C, Coenen M, Geffert K, Boger AH, Movsisyan A, Kratzer S, Klinger C, Wabnitz K, Strahwald B, Verboom B, Rehfuess E, Biallas RL, Jung-Sievers C, Voss S, Pfadenhauer LM. Measures implemented in the school setting to contain the COVID-19 pandemic: a rapid review. Cochrane Database of Systematic Reviews. 2022; 2022CD015029.      [DOI] 
Schwartz J, Reuters MC, Schallenburger M, Meier S, Roch C, Werner L, Oorschot B, Neukirchen M. Modelle guter Praxis: Alleine sterben ist ethisch nicht vertretbar. Praxis Palliative Care. 2022; 5429-36.
Wanner N, Andrieux G, Badia-i-Mompel P, et al . Molecular consequences of SARS-CoV-2 liver tropism. Nat Metab. 2022; 4310-319.      [DOI] 
Gruell H, et al . mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant. Nature Medicine. 2022;      [DOI] 
Liu Z, et al . Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19. Frontiers in immunology. 2022; 13838132.      [DOI] 
Bausewein C, Hodiamont F, Berges N, Ullrich A, Gerlach C, Oechsle K, Pauli B, Weber J, Stiel S, Schneider N, others . National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project. BMC palliative care. 2022; 21(1):10.      [DOI] 
Heinrich F, Roedl K, Jarczak D, et al . New Insights in the Occurrence of Venous Thromboembolism in Critically Ill Patients with COVID-19—A Large Postmortem and Clinical Analysis. Viruses. 2022; 14811.      [DOI] 
Arora P, et al . No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2. Cellular & Molecular Immunology. 2022;      [DOI] 
Ercanoglu MS, et al . No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults. iScience. 2022; 25103951.      [DOI] 
Zellmer S, Bachmann E, Muzalyova A, et al . One year of the COVID-19 pandemic in dental medical facilities in Germany: A questionnaire-based analysis. Int J Environ Res Public Health. 2022; 19(1):      [DOI] 
Jonigk D, Werlein C, Acker T, et al . Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?. Virchows Arch. 2022;      [DOI] 
Oorschot , others . PallPan Richtig handeln in der Betreuung Schwerkranker und Sterbender in Pandemiezeiten. Der Ophthalmologe. 2022;
Ebler J, Ebert P, Clarke WE, Rausch T, Audano PA, Houwaart T, Mao Y, Korbel JO, Eichler EE, Zody MC, Dilthey AT, Marschall T. Pangenome-based genome inference allows efficient and accurate genotyping across a wide spectrum of variant classes. Nature genetics. 2022; 54(4):518—525.      [DOI] 
Yüksel C, Sähn M, Kleines M, Brokmann J, Kuhl C, Truhn D, Ritter A, Isfort P, Schulze-Hagen M. Possible Alterations of Imaging Patterns in Computed Tomography for Delta-VOC of SARS-CoV-2. Rofo. 2022; 194(11):1229—1241.      [DOI] 
Lemhöfer C, Appel KS, Häuser W, Hettich N, Kohls M, Polidori MC. Post-COVID: Alles eine Frage der Definition?. Dtsch Med Wochenschr. 2022 Okt.; 147(21):1391—1397.
Heinrich F, Schröder A, Gerberding A, et al . Postmortem Antigen-Detecting Rapid Diagnostic Tests to Predict Infectivity of SARS-CoV-2-Associated Deaths. Emerg Infect Dis. 2022; 28244-247.      [DOI] 
Schwarz T, et al . Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis. Multiple Sclerosis Journal. 2022;      [DOI] 
Surov A, Kardas H, Besutti G, Pellegrini M, Ottone M, Onur M, Atak F, Erdemir A, Hocaoglu E, Yıldız Ö, Inci E, Cingöz E, Cingöz M, Dursun M, Korkmaz İ, Orhan Ç, Strobel A, Wienke A, Pech M. Prognostic Role of the Pectoralis Musculature in Patients with COVID-19. A Multicenter Study. Acad Radiol. 2022;      [DOI] 
Gorji H, Stauffer N, Lunati I, et al . Projection of healthcare demand in Germany and Switzerland urged by omicron wave (January-March 2022). MedRxiv. 2022;      [DOI] 
Authors V. RACOON: Das Radiological Cooperative Network zur Beantwortung der großen Fragen in der Radiologie. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2022; 194(01):95–95.      [DOI] 
Dächert C, Muenchhoff M, Graf A, et al . Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants. Med Microbiol Immunol. 2022; 211(1):      [DOI]      [Datei] 
Zickler M, Stanelle-Bertram S, Ehret S, et al . Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans. Cell Metab. 2022; 341-2.      [DOI] 
Neidhardt M, Gerlach S, Mieling R, et al . Robotic Tissue Sampling for Safe Post-Mortem Biopsy in Infectious Corpses. IEEE Trans. Med. Robot. Bionics. 2022; 494-105.      [DOI] 
Hammerschmidt SI, Thurm C, Bošnjak B, et al . Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination. Eur J Immunol. 2022; 52(2):      [DOI] 
Momsen Reincke S, et al . SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies. Science (New York, N.Y.). 2022;      [DOI] 
Layer E, Hoehl S, Widera M, Bojkova D, Westphal T, Gottschalk R, Boeddinghaus B, Schork J, Ciesek S, Goetsch U. SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach. International Journal of Infectious Diseases. 2022; 118126—131.      [DOI] 
Backhaus I, Hermsen D, Timm J, Boege F, Lübke N, Degode T, Göbels K, Dragano N. SARS-CoV-2 seroprevalence and determinants of infection in young adults: A population-based seroepidemiological study. Public Health. 2022;      [DOI] 
Arora P, et al . SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination. Cell Reports. 2022; 39110754.      [DOI] 
Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, Scheibenbogen C, Rabe KF, Maetzler W, Maetzler C, Laudien M, Frank D, Ballhausen S, Hermes A, Miljukov O, Haeusler KG, Mokhtari NEE, Witzenrath M, Vehreschild JJ, Krefting D, Pape D, Montellano FA, Kohls M, Morbach C, Störk S, Reese J, Keil T, Heuschmann P, Krawczak M, Schreiber S, group N. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022 Sep.; 51(101549):101549.      [DOI]  [Pubmed] 
Medenwald D, Brunner T, Christiansen H, et al . Shift of radiotherapy use during the first wave of the COVID-19 pandemic? An analysis of German inpatient data. Strahlenther Onkol. 2022; 198(4):334—345.      [DOI] 
Schug C, Geiser F, Hiebel N, Beschoner P, Jerg-Bretzke L, Albus C, Weidner K, Morawa E, Erim Y. Sick Leave and Intention to Quit the Job among Nursing Staff in German Hospitals during the COVID-19 Pandemic. International Journal of Environmental Research and Public Health. 2022 Feb.; 19(4):1947.      [DOI]      [Datei] 
Koll C, Hopff S, Meurers T, Lee C, Kohls M, Stellbrink C, Thibeault C, Reinke L, Steinbrecher S, Schreiber S, others . Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients. Sci Data. 2022; 9(1):776.      [DOI] 
Mayer M, Zellmer S, Zenk J, et al . Status quo after one year of COVID-19 pandemic in otolaryngological hospital-based departments and private practices in Germany. Eur Arch Otorhinolaryngol. 2022; 279(2):      [DOI] 
Hoven H, Dragano N, Angerer P, Apfelbacher C, Backhaus I, Hoffmann B, Icks A, Wilm S, Fangerau F, Söhner F. Striving for health equality: The importance of social determinants of health and ethical considerations in pandemic preparedness planning. International Journal of Public Health. 2022; 671604542.      [DOI] 
Peter L, et al . Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients. Molecular therapy. Methods & clinical development. 2022; 2552–73.      [DOI] 
Gruendner J, Deppenwiese N, Folz M, Köhler T, Kroll B, Prokosch H, Rosenau L, Rühle M, Scheidl M, Schüttler C, Sedlmayr B, Twrdik A, Kiel A, Majeed RW. The Architecture for a feasibility query portal for distributed COVID-19 Fast Healthcare Interoperability Resources (FHIR) patient data repositories: Design and Implementation Study. JMIR Medical Informatics. 2022 Mai; 10(5):e36709.      [DOI]  [Pubmed] 
Czypionka T, Iftekhar EN, Prainsack B, Priesemann V, Bauer S, Valdez AC, Cuschieri S, Glaab E, Grill E, Krutzinna J, Lionis C, Machado H, Martins C, Pavlakis GN, Perc M, Petelos E, Pickersgill M, Skupin A, Schernhammer E, Szczurek E, Tsiodras S, Willeit P, Wilmes P. The benefits, costs and feasibility of a low incidence COVID-19 strategy. The Lancet Regional Health-Europe. 2022; 13100294.      [DOI] 
Krasemann S, Haferkamp U, Pfefferle S, et al . The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Reports. 2022; 17307-320.      [DOI] 
Ackermann M, Tafforeau P, Wagner W, et al . The Bronchial Circulation in COVID-19 Pneumonia. Am J Respir Crit Care Med. 2022; 205121-125.      [DOI] 
Prokosch H, Bahls T, Bialke M, Eils J, Fegeler C, Gruendner J, Haarbrandt B, Hampf C, Hoffmann W, Hund H, Kampf M, Kapsner LA, Kasprzak P, Kohlbacher O, Krefting D, Mang JM, Marschollek M, Mate S, Müller A, Prasser F, Sass J, Semler S, Stenzhorn H, Thun S, Zenker S, Eils R. The COVID-19 Data Exchange Platform of the German university medicine. Stud. Health Technol. Inform.. 2022 Mai; 294674—678.
Schons M, Pilgram L, Reese J, Stecher M, Anton G, Appel KS, Bahmer T, Bartschke A, Bellinghausen C, Bernemann I, Brechtel M, Brinkmann F, Brünn C, Dhillon C, Fiessler C, Geisler R, Hamelmann E, Hansch S, Hanses F, Hanß S, Herold S, Heyder R, Hofmann A, Hopff SM, Horn A, Jakob C, Jiru-Hillmann S, Keil T, Khodamoradi Y, Kohls M, Kraus M, Krefting D, Kunze S, Kurth F, Lieb W, Lippert LJ, Lorbeer R, Lorenz-Depiereux B, Maetzler C, Miljukov O, Nauck M, Pape D, Püntmann V, Reinke L, Römmele C, Rudolph S, Sass J, Schäfer C, Schaller J, Schattschneider M, Scheer C, Scherer M, Schmidt S, Schmidt J, Seibel K, Stahl D, Steinbeis F, Störk S, Tauchert M, Tebbe JJ, Thibeault C, Toepfner N, Ungethüm K, Vadasz I, Valentin H, Wiedmann S, Zoller T, Nagel E, Krawczak M, Kalle C, Illig T, Schreiber S, Witzenrath M, Heuschmann P, Vehreschild JJ, Group NR. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics. Eur. J. Epidemiol.. 2022 Aug.; 37(8):849—870.      [DOI]  [Pubmed] 
Borusiak P, Mazheika Y, Bauer S, Haberlandt E, Krois I, Fricke C, Simon L, Beschoner P, Jerg-Bretzke L, Geiser F, Hiebel N, Weidner K, Albus C, Morawa E, Erim Y. The impact of the COVID-19 pandemic on pediatric developmental services: a cross-sectional study on overall burden and mental health status. Arch Public Health. 2022; 80(1):113.
Hannemann J, Abdalrahman A, Erim Y, Morawa E, Jerg-Bretzke L, Beschoner P, Geiser F, Hiebel N, Weidner K, Steudte-Schmiedgen S, Albus C. The impact of the COVID-19 pandemic on the mental health of medical staff considering the interplay of pandemic burden and psychosocial resources-A rapid systematic review. PLoS One. 2022; 17(2):e0264290.      [DOI] 
Schreiber A, Viemann D, Schöning J, Schloer S, Mecate Zambrano A, Brunotte ea. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses. Cell Mol Life Sci. 2022; 7965.      [DOI] 
Wratil PR, Stern M, Priller A, et al . Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. Nat Med. 2022;      [DOI] 
Kamp J, Neubert L, Ackermann M, et al . Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19. Int J Mol Sci. 2022; 23      [DOI] 
Wulff A, Biermann P, Landesberger T, Baumgartl T, Schmidt C, Alhaji AY, Schick K, Waldstein P, Zhu Y, Krefting D, Scheithauer S, Marschollek M. Tracing COVID-19 Infection Chains Within Healthcare Institutions - Another Brick in the Wall Against SARS-CoV-2. Studies in health technology and informatics. 2022; 290699—703.      [DOI] 
Schug C, Erim Y, Geiser F, Hiebel N, Beschoner P, Jerg-Bretzke L, Albus C, Weidner K, Steudte-Schmiedgen S, Borho A, Lieb M, Morawa E. Vaccination willingness against COVID-19 among healthcare workers in Germany: Results from a University Medicine Network survey between November 2020 and January 2021. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2022 Jan.; 65(1):74—85.      [DOI]      [Datei]